Health news round-up: NICE approvals, fighting AMR and medicines safety concerns Senior clinical reporter Joanna Robertson summarises some important developments in health news.…
First home-based digital technologies approved for cardiac rehabilitation The National Institute for Health and Care Excellence said digital technologies could offset the low uptake of traditional cardiac rehabilitation programmes.…
Urinary tract infection in adults: diagnosis, management and prevention This article covers the optimisation of patient outcomes through prompt diagnosis of, and appropriate antibiotic prescribing for, urinary tract infections.…
NHS home testing identifies hundreds with hepatitis C More than 105,000 people in England have ordered the test since the home-testing service launched in May 2023, with more than 200 testing positive.…
Major step forward as bladder cancer treatment approved in England The National Institute for Health and Care Excellence estimates that more than 1,200 people each year in England could benefit from the enfortumab vedotin and pembrolizumab combination therapy.…
Vaccines often overlooked in antimicrobial stewardship, microbiologists warn Attendees of a roundtable organised by the Microbiology Society concluded that there was an “urgent need to strengthen the evidence base for vaccine impact on AMR”.…
Frailty and the patient journey How to recognise opportunities for medicines optimisation and rationalisation during the course of the patient journey following a frailty-related hospital admission.…
Reviewing our clinical services and implementing job planning to get the best out of our pharmacy team How deputy chief pharmacist Poureya Aghakhani and his team have responded to financial pressures to reaffirm their purpose.…
MHRA approves UK’s first immunotherapy for type 1 diabetes Teplizumab (Tzield; Sanofi) has been approved by the MHRA for delaying the progression of type 1 diabetes mellitus.…
More than 40 organisations commit to include older adults in research The statement of intent outlined commitments to “challenge any unwarranted exclusion of older adults or those with long-term conditions (multimorbidity) from research”.…
